Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation

BACKGROUND AND OBJECTIVE: Anastrozole is a well-established active pharmaceutical ingredient (API) used for the treatment of hormone-sensitive breast cancer (BC) in postmenopausal women. However, treatment with the only available oral formulation is often associated with concentration-dependent seri...

Descripción completa

Detalles Bibliográficos
Autores principales: Regenthal, Ralf, Voskanian, Margarita, Baumann, Frank, Teichert, Jens, Brätter, Christian, Aigner, Achim, Abraham, Getu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219411/
https://www.ncbi.nlm.nih.gov/pubmed/30464397
http://dx.doi.org/10.2147/DDDT.S170764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219411/
https://www.ncbi.nlm.nih.gov/pubmed/30464397
http://dx.doi.org/10.2147/DDDT.S170764

Ejemplares similares